Mrs. Mary J. Michalski, M.S. C.C.C.-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 702 W Dolf St, Colby, WI 54421 Phone: 715-223-2352 Fax: 715-223-3972 |
Katie Iverson, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 702 W Dolf St, Colby, WI 54421 Phone: 715-223-2352 |
News Archive
For Christina Nester, the pandemic lull in Massachusetts lasted about three months through summer into early fall. In late June, St. Vincent Hospital had resumed elective surgeries, and the unit the 48-year-old nurse works on switched back from taking care of only COVID-19 patients to its pre-pandemic roster of patients recovering from gallbladder operations, mastectomies and other surgeries.
During a recent interview with The Hill's "Blog Briefing Room," Melinda Gates, co-chair of the Bill & Melinda Gates Foundation, praised former President George W. Bush for the enactment of PEPFAR and commended the Obama administration's commitment to global health issues and for "being very open minded [and] saying we don't have to go back and reinvent the wheel."
EpiCept Corporation today announced that Nasdaq notified the Company that it has regained compliance with the minimum bid price requirement in Listing Rule 5550(a)(2) and met the requirements of the Nasdaq Listing Qualification Panel (the "Panel") decision dated November 2, 2009. Accordingly, the Panel has determined to continue the listing of the Company's common stock on The Nasdaq Stock Market.
Having obese parents is the factor that most increases the likelihood of childhood obesity, according to Stanford University School of Medicine researchers.
The John Theurer Cancer Center at Hackensack University Medical Center announced today important research findings that will be presented at the American Society of Clinical Oncology annual meeting taking place June 4 - 8, 2010 in Chicago. Research highlights include a comparison of first-line treatments for an aggressive form of lymphoma, the efficacy and safety of a new genetically engineered cancer therapy, and the value of a commonly used tool for staging lymphoma.
› Verified 6 days ago